Long-term infant outcomes after hyperbaric oxygen treatment for acute carbon monoxide poisoning during pregnancy.


Journal

Diving and hyperbaric medicine
ISSN: 1833-3516
Titre abrégé: Diving Hyperb Med
Pays: Australia
ID NLM: 101282742

Informations de publication

Date de publication:
30 Sep 2021
Historique:
received: 18 12 2020
accepted: 16 05 2021
entrez: 21 9 2021
pubmed: 22 9 2021
medline: 24 9 2021
Statut: ppublish

Résumé

Carbon monoxide (CO) poisoning in pregnant women is linked to foetal mortality of 36-67%. This study assessed long-term fetal outcomes following hyperbaric oxygen treatment (HBOT) for acute CO poisoning in pregnant women. The effects of clinical severity parameters and pregnancy trimester were also analysed. A retrospective review of 28 pregnant patients who received HBOT for acute CO poisoning between January 2013-June 2016 was made. Adverse events, birth week, birth weight-height, birth complications, and the age of crawling, walking independently, talking (first words) of their children were recorded. Twenty-eight singleton pregnancies were included. One fetus was dead before HBOT. Three adverse events were reported: abortion, premature birth, and limb malformation. All remaining patients (n = 24) delivered healthy term infants and reported normal neurophysiological development. At final interview the median age of babies was 34 (8-44) months and none had any diagnosed disease. There was no relationship between clinical severity parameters and long-term outcomes. However, the pregnancy trimester at the time of CO poisoning had a significant relationship to birth weight (P = 0.029). Also, the week of pregnancy at the time of the incident correlated with the age of walking independently (P = 0.043, r = 0.436). This is the largest relevant series and longest follow-up to date. Adverse outcomes were likely incidental because the mothers' medical histories revealed alternative aetiologies. There was no definite evidence of fetal morbidity or mortality after HBOT in this study. HBOT may improve long-term fetal outcomes after in-utero CO poisoning without complications.

Identifiants

pubmed: 34547775
doi: 10.28920/dhm51.3.248-255
pmc: PMC8608441
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

248-255

Informations de copyright

Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Références

MMWR Morb Mortal Wkly Rep. 2008 Aug 22;57(33):896-9
pubmed: 18716581
BJOG. 2000 Jul;107(7):833-8
pubmed: 10901551
PLoS One. 2017 Feb 23;12(2):e0170946
pubmed: 28231292
Case Rep Obstet Gynecol. 2015;2015:687975
pubmed: 25834750
Turk J Pediatr. 2012 May-Jun;54(3):260-8
pubmed: 23094536
Reprod Toxicol. 1991;5(5):397-403
pubmed: 1806148
Undersea Hyperb Med. 2018 Jul-Aug;45(4):453-456
pubmed: 30241125
Proc Soc Exp Biol Med. 1964 Aug-Sep;116:975-6
pubmed: 14230403
Rev Neurol (Paris). 1978 Aug-Sep;134(8-9):485-95
pubmed: 749124
Obstet Gynecol Surv. 2015 Nov;70(11):705-12
pubmed: 26584719
Semin Fetal Neonatal Med. 2016 Apr;21(2):68-73
pubmed: 26794420
BMJ. 2019 Mar 20;364:l869
pubmed: 30894356
J Clin Anesth. 1995 Feb;7(1):82-7
pubmed: 7772366
B-ENT. 2013;9(4):299-306
pubmed: 24597105
N Engl J Med. 2002 Oct 3;347(14):1057-67
pubmed: 12362006
Am J Obstet Gynecol. 1964 Dec 1;90:854-8
pubmed: 14241507
Rev Environ Health. 2018 Sep 25;33(3):247-264
pubmed: 29975668
JAMA. 1989 Feb 17;261(7):1039-43
pubmed: 2644457
Intensive Care Med. 1991;17(5):289-92
pubmed: 1939875
Emerg Med J. 2001 Sep;18(5):399-401
pubmed: 11559621
J Pediatr Surg. 1988 Mar;23(3):275-7
pubmed: 2895805
Acta Paediatr Suppl. 2006 Apr;450:86-95
pubmed: 16817682
Inhal Toxicol. 2010 Oct;22(12):1026-31
pubmed: 20843278
J Emerg Nurs. 2015 Nov;41(6):479-83
pubmed: 26409658
Bull Acad Natl Med. 2013 Mar;197(3):677-94; discussion 695-7
pubmed: 25163349
Arch Gynecol Obstet. 2010 Feb;281(2):251-4
pubmed: 19504116

Auteurs

Kubra Ozgok-Kangal (K)

Department of Undersea and Hyperbaric Medicine, Saglik Bilimleri Universitesi, Gulhane Egitim ve Arastirma Hastanesi, Ankara, Turkey.
Dr Kubra Ozgok-Kangal, Gen Dr Tevfik Saglam Cad. SBÜ-Gülhane Eğitim ve Araştırma Hastanesi, Sualtı Hekimliği ve Hiperbarik Tıp Kliniği, Etlik, Ankara, Turkey, ORCID: 0000-0002-2449-4821. kubra_ozgk@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH